12-29-2017 08:03 AM CET - Health & Medicine
Print

Global Anti-Microbial/ Anti-Fungal Tests Market Expected to Reach Value of US$ 1.2 billion by 2027 End

Press release from: Market Research Reports Search Engine - MRRSE
MRRSE
MRRSE
This research report offers a comprehensive analysis of the “Anti-microbial/Anti-fungal Tests Market: Reference Laboratories Anticipated to be the Fastest Growing End User Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027“The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market.

Request to view Sample Report @ www.mrrse.com/sample/4103

Local Governments Entering into Partnerships with Manufacturers in Anti-microbial/Anti-fungal Tests Market

Government partnerships and tendering between diagnostic kit manufacturers is poised to provide manufacturers with substantial long-term opportunities in the anti-microbial/ anti-fungal tests market. Governments in Latin American and Asian countries are working overtime to eradicate highly infectious diseases by providing free medication and diagnostic tests to their underprivileged citizens through government-backed programs. In order to achieve these objectives, local authorities need a constant supply of diagnostic kits and manufacture tendering or partnerships are the best solution to this. Partnership / tendering benefits manufacturers as it provides them with a stable revenue stream for a specific period of time. Emerging economies such as India and Brazil have favourable opportunities for tendering and this is expected to boost the anti-microbial/ anti-fungal tests market over the forecast period.

Companies Strengthening Distribution Channels to Target All End Users in Anti-microbial/Anti-fungal Tests Market

At present, companies in the anti-microbial/ anti-fungal tests market are investing in their distribution networks to increase their sales in untapped markets. An effective way to do so is through strategic partnerships and alliances with local suppliers. These partnerships have proven to be critically important to manufacturers because they provide an edge over the competition and allow companies to introduce their products into niche markets, increasing their user base. Hospitals are predicted to be the largest end-user in the global anti-microbial/ anti-fungal tests market for the foreseeable future and should push past US$ 1.2 billion by end 2027.

Browse Full Report with TOC @ www.mrrse.com/anti-microbial-anti-fungal-tests-market

Lack of Innovation Culture a Challenge to Overcome in the Anti-microbial/Anti-Fungal Tests Market

Healthcare providers and medical personnel in general tend to be risk averse and extremely hesitant to change any policies or procedures. There have been several instances in the field of in-vitro diagnostics where physicians have been resistant to change if the impending innovation is likely to reduce the organizational income stream. The management and organization of diagnostic services can further exacerbate this problem. This constraint is felt even more acutely in emerging economies where innovations performed and maintained by well-funded labs do not work in resource-starved healthcare facilities in far-flung rural areas. Therefore, companies would do well to focus on the hospital segment of the APEJ anti-microbial/ anti-fungal tests market as it is anticipated to push past US$ 250 million in 2027.

Quality Education and Training Need of the Hour in the Anti-microbial/Anti-fungal Tests Market

For a seamless transition of molecular diagnostics from a lab to a clinic, extensive optimization is required to interpret the results accurately. Diagnostic and clinical labs need highly skilled professionals who are experts in the medical and healthcare field. Unfortunately, limited resources in emerging economies mean that they can allocate only a sliver of public funds to clinical labs and an even smaller percentage of this to quality assurance. Well-trained personnel are absolutely essential and are in short supply in the 21st century. A WHO report states that Sub-Saharan Africa has an acute healthcare crisis with only 168 medical schools in 47 countries. In Sub-Saharan Africa, 11 countries do not have a single medical school while 24 have only one. Although hospitals are the largest end-user in MEA anti-microbial/ anti-fungal tests market, the reference laboratory segment is projected to witness a higher CAGR of 5.6% from 2017 to 2027.

Enquire about this Report @ www.mrrse.com/enquiry/4103

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: www.mrrse.com/
Read More Industry News At: www.industrynewsanalysis.com/

This release was published on openPR.
News-ID: 879317 • Views: 142
More releases More releases
Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.

You can edit or delete your press release here: